Volume 18, Issue 3 pp. 260-267

Adverse events and behavioral reactions related to ketamine based anesthesia for anorectal manometry in children

PRITI G. DALAL MD FRCA

PRITI G. DALAL MD FRCA

Department of Anesthesia, Penn State Milton Hershey Medical Center, Hershey, PA, USA

Search for more papers by this author
DAN TAYLOR FRCA

DAN TAYLOR FRCA

Department of Anaesthesia, The Evelina Children’s Hospital, Guy’s & St Thomas’ NHS Foundation Trust, London, UK

Search for more papers by this author
NICOLA SOMERVILLE FRCA

NICOLA SOMERVILLE FRCA

Department of Anaesthetics, Kent and Canterbury Hospital NHS Trust, Kent, UK

Search for more papers by this author
NEENA SETH FRCA

NEENA SETH FRCA

Department of Anaesthesia, The Evelina Children’s Hospital, Guy’s & St Thomas’ NHS Foundation Trust, London, UK

Search for more papers by this author
First published: 22 January 2008
Citations: 11
Dr Priti G Dalal, MD FRCA, Assistant Professor, Department of Anesthesiology, H187, Penn State Milton S Hershey Medical Center College of Medicine, 500 University Drive, Hershey, PA 17033, USA (email: [email protected]).

This study was partly presented as a poster at the 13th World Congress of Anaesthesiologists, Paris, April 2004 and at the 58th Postgraduate Assembly, New York, December 2004, and presented as a poster at the Society for Pediatric Anesthesia meeting, Phoenix, Arizona, March 2007. This study attributed to the Department of Anesthetics, Guy’s & St Thomas’ NHS Foundation Trust, London, UK.

Summary

Background: Pediatric patients undergoing anorectal manometry require ketamine anesthesia as other anesthetic agents affect the anorectal sphincter tone. The aim of this prospective observational audit was to evaluate our practice and report the occurrence of adverse events and behavioral reactions related to the use of ketamine, propofol, and midazolam combinations.

Methods: Eighty-two consecutive pediatric patients (mean age 8.06 ± 3.43 years) undergoing anorectal manometry were audited over a 1-year period. After a routine ketamine anesthetic some children were administered midazolam 0.1 mg·kg−1, at the discretion of the attending anesthetist. Children requiring anal stretch following manometry studies also received propofol 3–5 mg·kg−1. Intra- and postoperative adverse events, times to spontaneous awakening and discharge from the PACU were noted. Postoperative behavioral reactions were noted in the PACU and at follow-up interviews on the first postoperative day and after a period of 1 month.

Results: Following completion of the audit, all patients fell into one of the four groups depending on the anesthetic agents they received: K (ketamine only, n = 16), KM (ketamine and midazolam, n = 10), KP (ketamine and propofol, n = 27), and KPM (ketamine, propofol, and midazolam, n = 29). There was no difference in the occurrence of behavioral reactions between the four groups at the three stages of follow-up. Overall, five patients reported ‘new onset’ nightmares that had resolved completely at the 3-month follow-up. The time to spontaneous awakening was shorter for K group (17.8 min ± 20.2) vs KPM group (61.7 min ± 24.4; P < 0.001). The times to discharge in minutes was also shorter in the K group (54.5 min, IQR 30–75 vs 90 min IQR 78–120; P < 0.001). Administration of propofol appeared to have an antiemetic effect [odds ratio (OR) 0.1, 95% confidence intervals (CI) 0.02–0.58, P < 0.009] in the recovery unit.

Conclusions: Our study findings suggest that, besides significantly prolonging time to spontaneous awakening and PACU discharge, neither the use of midazolam, propofol, or combinations is beneficial in preventing the occurrence of behavioral reactions following ketamine anesthesia. Behavioral reactions were common but did not appear to be long-term. Drug combinations with ketamine may have other benefits such as antiemesis.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.